Because of a lapse in government funding, the information on this website may not be up to date transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit

Updates regarding government operating status and resumption of normal operations can be found at

NCI Dictionary of Cancer Terms

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

The NCI Dictionary of Cancer Terms features 8,188 terms related to cancer and medicine.

We offer a widget that you can add to your website to let users look up cancer-related terms. Get NCI’s Dictionary of Cancer Terms Widget.

(KA-boh-ZAN-tih-nib ... MA-layt)
A drug used to treat advanced renal cell carcinoma (a type of kidney cancer) that was treated with antiangiogenesis therapy (a type of anticancer therapy). It is used under the brand name Cabometyx to treat this cancer. It is also used under the brand name Cometriq to treat progressive medullary thyroid cancer that has spread to other parts of the body. Cabozantinib-s-malate is also being studied in the treatment of other types of cancer. It blocks certain proteins, which may help keep cancer cells from growing. It may also prevent the growth of new blood vessels that tumors need to grow. Cabozantinib-s-malate is a type of tyrosine kinase inhibitor and a type of angiogenesis inhibitor.